Product Pipline Avirmax Biopharma Inc. is at clinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development. Indication Lead Design & Production AAV - Vector Biochemical Potency Preclinical IND - Enabling Phase 1 Commercial Rights Milestone Wet AMD incl. PCV ABI-110 0% Enrolling GA / dry AMD ABI-201 0% IND 2H25 PDR ABI-202 0% IND 2H26 Glaucoma ABI-902 0% IND 2H26 AMD: Age-related macular degenerationGA: geographic atrophyPCV: Polypoidal choroidal vasculopathyPDR: Proliferative diabetic retinopathy